Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This combination of electrolytes, buffers, and dextrose is used as a replacement solution in continuous renal replacement therapy (CRRT), specifically for hemofiltration and hemodiafiltration. The solution is designed to replace water and essential electrolytes (sodium, potassium, calcium, magnesium, chloride, and phosphate) that are removed during the filtration process. It also contains an alkalinizing buffer (bicarbonate or its precursor lactate) to help restore and maintain acid-base balance in patients with acute kidney injury or renal failure. The inclusion of anhydrous dextrose provides a caloric source and helps maintain blood glucose levels during the procedure. These solutions are pharmacologically inactive and work by restoring plasma electrolyte concentrations to clinically desired levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium chloride + sodium bicarbonate + potassium chloride + lactic acid + calcium chloride + sodium chloride + anhydrous dextrose + sodium phosphate, dibasic.